Southeast Asia has seen her fair share of Nipah virus outbreaks. How do we stay ahead of the enemy? by Dr Sunny Himansu The recent use and success of messenger RNA (mRNA) vaccines in protecting...
Advancements in the dengue management landscape indicate a new era in the way we mitigate the impacts of the infectious disease. by Junghun Justin Kim Many of us living in Asia are well acquainted...
Immunisation is one of the most successful public health interventions but progress in the last two years has stalled or even reversed. COVID-19 and the threat of future pandemics have and will...
The approval of TAK-003 indicates a new era in the fight against dengue in Indonesia, which faces one of the world’s highest burdens of the disease. Takeda announced in August that its live...
Moderna advances global health commitment with mRNA vaccine candidate against the Nipah virus, a lethal pathogen with pandemic potential. Moderna, Inc., a biotechnology company pioneering messenger...
A novel oral vaccine system developed using a sugar-controlled bacteria robot may be used as an antigen delivery and display platform that can prevent a variety of diseases. A recent study led by...
Considering the ongoing pandemic and the current COVID-19 virus strains, the role of vaccines in controlling infectious diseases is unparalleled and critical. Yet, vaccine access and inequity remain...
The new facility is part of a S$80 million vaccine development and manufacturing hub in Singapore. Hilleman Laboratories, an organisation with a mission to develop affordable vaccines...
COVID-19 has highlighted the cracks in our current healthcare systems, protocols, and policies. How can we address these vulnerabilities and what more can we look forward to in the years to come? The...
A robust T cell response can be expected to offer protection and help to prevent severe disease caused by Omicron. Since it was first detected in Botswana, South Africa, and Hong Kong in November...
The vaccine provides over 90 per cent protection against shingles across all age groups over 50, with robust and sustained efficacy. GlaxoSmithKline (GSK) Singapore announced that a new vaccine to...
COVID-19 has highlighted the urgency for ASEAN leaders to collaborate and strategise viable and sustainable solutions for more resilient healthcare systems to withstand future challenges. It’s not...
